Posted by Michael Wonder on 06 Jun 2023
FDA announces additional steps to modernise clinical trials
6 June 2023 - Agency requesting feedback on the draft recommendations and how they should be applied to increasingly diverse trial types and data sources.
Today, the US FDA is announcing the availability of a draft guidance with updated recommendations for good clinical practices aimed at modernising the design and conduct of clinical trials, making them more agile without compromising data integrity or participant protections.
